Target
Voltage-dependent calcium channel gamma-2 subunit
Ligand
BDBM311850
Substrate
n/a
Meas. Tech.
Calcium Flux Assay
IC50
0.251±n/a nM
Citation
 Ameriks, MKLaforteza, BNLebold, TPRavula, SSavall, BMShireman, BT Fused azaheterocyclic compounds and their use as AMPA receptor modulators US Patent  US10155769 Publication Date 12/18/2018 
Target
Name:
Voltage-dependent calcium channel gamma-2 subunit
Synonyms:
CACNG2 | CCG2_HUMAN | Neuronal voltage-gated calcium channel gamma-2 subunit | TARP gamma-2 | Transmembrane AMPAR regulatory protein gamma-2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
35977.54
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
323
Sequence:
MGLFDRGVQMLLTTVGAFAAFSLMTIAVGTDYWLYSRGVCKTKSVSENETSKKNEEVMTHSGLWRTCCLEGNFKGLCKQIDHFPEDADYEADTAEYFLRAVRASSIFPILSVILLFMGGLCIAASEFYKTRHNIILSAGIFFVSAGLSNIIGIIVYISANAGDPSKSDSKKNSYSYGWSFYFGALSFIIAEMVGVLAVHMFIDRHKQLRATARATDYLQASAITRIPSYRYRYQRRSRSSSRSTEPSHSRDASPVGIKGFNTLPSTEISMYTLSRDPLKAATTPTATYNSDRDNSFLQVHNCIQKENKDSLHSNTANRRTTPV
  
Inhibitor
Name:
BDBM311850
Synonyms:
2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trifluoromethyl)imidazo[1,2-a]pyridine | US10155769, Example 91
Type:
Small organic molecule
Emp. Form.:
C19H15F3N4
Mol. Mass.:
356.3444
SMILES:
Cc1cc(cc2cn[nH]c12)-c1c(ccn2cc(nc12)C1CC1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: